Navigation Links
Ventria's Child Health Product Recognized for Its Promise

SACRAMENTO, Calif., Nov. 12 /PRNewswire/ -- A review article published in the Journal of Infection entitled, "Advances in defining etiology and new therapeutic approaches in acute diarrhea" [1], recognized Ventria's Child Health Product for its benefit to children who are suffering from acute diarrhea. The review was published online and is also available in the November print version.

Ventria's product is a medical food which can be added to standard electrolyte solutions to help children get better faster. The product was designed by researchers studying the advantages of breastfeeding for children. Ventria developed a method to affordably manufacture the important nutritional components of breast milk in rice. By replenishing these nutritional components, children suffering from diarrhea recovered quicker by one and a half days compared to the current standard electrolyte product used for rehydration during diarrhea.

William Greenough III, MD, Professor of Medicine at Johns Hopkins University and a world-renowned expert in pediatric diarrhea said "I am hoping that Ventria's product might be the first improvement that would be widely added to oral hydration solutions, which are consumed by at least half of the world's children".

In the United States there are an estimated 4.5 million hospital visits for childhood diarrhea. Globally, childhood diarrhea is the second leading killer of children under the age of 5, claiming 2 million lives annually.

"Diarrheal illnesses are a major reason for children seeing their physician and a major cause of emergency room visits," said Robert Wittler, MD, Professor, Pediatric Infectious Diseases, Kansas University School of Medicine at Wichita. "Oral rehydration is a safe and effective way to treat most diarrheal illnesses and this study confirms the advantages of adding proteins contained in breast milk to oral rehydration solution. This is an important study as decreasing the duration of diarrhea lessens the likelihood of children becoming significantly dehydrated and allows children to return to daycare and school quicker and their parents who work outside the home can return to work sooner."

"Ventria has been developing this product for several years and we are pleased with the recognition from leaders in the medical community. We anticipate a successful market introduction of this product so that we can make a positive contribution to child health on a global basis." said Scott Deeter, President and CEO, Ventria Bioscience.

(1) Marcos, L, Dupont, H

Advances in defining etiology and new therapeutic approaches in acute


Journal of Infection. 2007 55, 385-393

For more information, see our website at Ventria Bioscience

Statements in this announcement other than historical data and information constitute forward looking statements that involve risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements. Potential risks and uncertainties may include, but are not limited to, recent changes in senior management, fluctuations in operating results, market conditions and changes in technology and increased competition.

SOURCE Ventria Bioscience
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Children of depressed moms do better when dad is involved, SLU researcher finds
2. High pollution linked to poor lung function growth in children in Mexico City
3. Genetic predisposition increases childhood asthma risk
4. NYC-area 1st: Morgan Stanley Childrens Hospital performs transcatheter pulmonary valve replacement
5. Obese Children Miss More School Days
6. Treating diabetes during pregnancy can break link to childhood obesity
7. Ultra-Runner to Run 63 Marathons in 63 Days for Children with Incurable Disease
8. Chinas 1-child policy could backfire on its elderly
9. Psoriasis Cure Now offers Back to School Resources for Parents of Children with Psoriasis
10. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
11. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... It’s official: Tattoo taboo is a ... number even greater among Millennials (a whopping one in three aged 18 to 25 ... who are dissatisfied with their ink. In fact, RealSelf , the world’s largest ...
(Date:12/1/2015)... Illinois (PRWEB) , ... December 01, 2015 , ... ... and share medical images have been lifted as IMAGE Information Systems launches MED-TAB™ ... Society of North America Annual Meeting from November 29 to December 4, 2015. ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... the United States. Podiatrists are well aware that psychology-based patient non-compliance (disobedience of ... often catastrophic contributors to diseases of the diabetic foot. The American Board ...
(Date:12/1/2015)... ... December 01, 2015 , ... The ... adjunctive imaging is the focus of numerous abstracts accepted for presentation here, at ... 2015. Nine abstracts highlight the use of Volpara Solutions’ quantitative breast imaging ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... must mark the film for accurate interpretation by the radiologist. The marking utensils ... inventor from Sacramento, Calif., has found a way to alleviate this problem. , ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 01, 2015 ... announced the addition of the ... Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, ... report to their offering. --> ... addition of the "2016 Europe ...
(Date:12/1/2015)... ) has ... and Disposables Market by product, by Animal - ... offering. --> ) has announced ... Disposables Market by product, by Animal - Global ... --> Research and Markets ( ...
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: ... of chronic pain, announced today that the company will present ... held December 1-3 at the Luxe Sunset Boulevard Hotel in ... , CEO of Relmada Therapeutics, will present on Thursday, December ... . Please register at least 10 minutes ...
Breaking Medicine Technology: